Both KDM3A and DCLK1 mRNA levels are higher in human pancreatic tumor tissues than in non-tumor pancreatic tissues, and their expression is correlated with shorter survival times of patients with pancreatic cancer. This evidence concerns the gene KDM3A and pancreatic neoplasm.